Ketamine as treatment for treatment-resistant depression moves out of research phase

Ketamine, known as an anesthetic and recreational drug, is increasingly being used in the treatment of treatment-resistant depression. The drug appears to have a positive effect on patients who do not respond to standard antidepressants.

According to GGZ Nieuws, the drug is now approved for use in clinical practice. This means that doctors can prescribe it to patients who do not respond to regular treatments.

The mechanism of action of ketamine is different from that of traditional antidepressants. It works quickly and can have an effect within a few hours or days, whereas antidepressants usually take weeks.

However, caution is advised. Ketamine can have side effects and should be administered under strict medical supervision. Its use is limited to specialized centers.

This report is a summary based on the mentioned source and is not medical advice. Always consult a doctor or pharmacist if you have complaints.